Results 11 to 20 of about 14,696 (160)

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. [PDF]

Eur Respir J, 2021
BackgroundData from the INMARK trial were used to investigate the feasibility and validity of home spirometry as a measure of lung function decline in patients with idiopathic pulmonary fibrosis (IPF).MethodsSubjects with IPF and preserved forced vital capacity (FVC) were randomised to receive nintedanib or placebo for 12 weeks followed by open-label ...
Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM, INMARK trial investigators.   +13 more
europepmc   +19 more sources

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers [PDF]

Respiratory Research, 2018
In idiopathic pulmonary fibrosis (IPF), home monitoring experiences are limited, not yet real-time available nor implemented in daily care. We evaluated feasibility and potential barriers of a new home monitoring program with real-time wireless home ...
C. C. Moor, M. Wapenaar, J. R. Miedema, J. J. M. Geelhoed, P. P. Chandoesing, M. S. Wijsenbeek   +5 more
doaj   +5 more sources

Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis [PDF]

European Respiratory Review, 2023
Background: The number of patients completing unsupervised home spirometry has recently increased due to more widely available portable technology and the COVID-19 pandemic, despite a lack of solid evidence to support it.
Rohan Anand, Rebecca McLeese, John Busby, Jonathan Stewart, Mike Clarke, William D-C. Man, Judy Bradley   +6 more
doaj   +4 more sources

The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study [PDF]

Journal of Medical Internet Research
BackgroundHome spirometers have been widely implemented in the treatment of people with cystic fibrosis (CF). Frequent spirometry measurements at home could lead to earlier detection of exacerbations.
Pia Bertram, Martinus C Oppelaar, Michiel AGE Bannier, Monique HE Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, Lennart Conemans, Bart L Rottier, Marianne Nuijsink, Lara S van den Wijngaart, Peter JFM Merkus, Jolt Roukema   +12 more
doaj   +4 more sources

Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process [PDF]

BMJ Open Quality, 2021
Aim The specific aims of this quality improvement (QI) project were to increase the percentage of eligible adult CF patients who owned an HSs from 37% to 85% and to increase the percentage of adult CF patients seen at UVA with available spirometry in ...
Heather Bruschwein, Martina Compton, Rhonda List, Elissa Starheim, Lindsay Somerville, Lauren Williamson, Rachel Murray, Deirdre Jennings, Dana Albon   +8 more
doaj   +3 more sources

Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study [PDF]

Rheumatology, 2021
Objectives: Frequent monitoring of forced vital capacity at home may be of added value in patients with SSc-associated interstitial lung disease (SSc-ILD) to monitor disease progression and guide treatment decisions. The aim of this study was to evaluate
Catharina C Moor, Sander I van Leuven, Marlies S Wijsenbeek   +2 more
exaly   +4 more sources

Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed‐Effects Hidden Markov Model [PDF]

CPT: Pharmacometrics & Systems Pharmacology
Clinical trials in asthma and chronic obstructive pulmonary disease often use exacerbation risk as the primary endpoint. However, exacerbations occur with low frequency, leading to long and costly clinical trials.
Ludvig Jakobsson, Marcus Baaz, Jacob Leander, Philip Gerlee, Mats Jirstrand   +4 more
doaj   +3 more sources

Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study

Pediatric Pulmonology
AbstractObjectivesTelehealth and home spirometry feasibility for children has been established, but their impact on cystic fibrosis (CF) disease progression remains unassessed. We aimed to evaluate the effects of telehealth and home spirometry on CF disease progression and care.MethodsChildren with CF aged 5–17 years from all Swedish CF centers were ...
Jakob Medbo, Henrik Imberg, Christina Krantz   +2 more
exaly   +5 more sources

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease [PDF]

Respiratory Research, 2022
Background Patients with interstitial lung disease (ILD) require regular physician visits and referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities to monitor disease trajectory and response to treatment ...
Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek   +10 more
doaj   +2 more sources

A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis. [PDF]

J Cyst Fibros, 2022
The COVID-19 pandemic has accelerated the transition to telehealth, including the use of home spirometry in cystic fibrosis. Evaluating the accuracy and precision of longitudinal home spirometry is a requisite for telehealth-based research. This secondary analysis of a CF study (eICE) evaluates whether there are cross-sectional or longitudinal ...
Paynter A, Khan U, Heltshe SL, Goss CH, Lechtzin N, Hamblett NM.   +5 more
europepmc   +4 more sources